The leadership of Heron Therapeutics (often referenced under its ticker HRTX) is spearheaded by its executive team overseeing the commercialization of its acute care and oncology supportive care products. The executive management works to expand market adoption for its proprietary therapeutic formulations in hospital and clinic settings. Investors tracking corporate governance look closely at executive execution to gauge how effectively the management team is steering the commercial portfolio toward sustained operational profitability.